迈克生物：公司采用“设备+软件+试剂+服务”组合定价策略

Core Viewpoint - The company, Maike Bio (300463), has adopted a pricing strategy that combines "equipment + software + reagents + services" based on the differences in hospital scale, procurement entities, and cooperation models [1] Group 1 - The company responds to investor inquiries on its interactive platform regarding its revenue structure [1] - The specific details of the revenue structure can be found in the company's periodic reports [1]